461 related articles for article (PubMed ID: 7544833)
21. Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.
Celluzzi CM; Falo LD
J Invest Dermatol; 1997 May; 108(5):716-20. PubMed ID: 9129221
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
23. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
Goldberg J; Shrikant P; Mescher MF
J Immunol; 2003 Jan; 170(1):228-35. PubMed ID: 12496404
[TBL] [Abstract][Full Text] [Related]
24. Antigen-specific cytotoxicity and cell number of adoptively transferred T cells are efficiently maintained in vivo by re-stimulation with an antigen/interleukin-2 fusion protein.
Kang BY; Lim YS; Chung SW; Kim EJ; Kim SH; Hwang SY; Kim TS
Int J Cancer; 1999 Aug; 82(4):569-73. PubMed ID: 10404072
[TBL] [Abstract][Full Text] [Related]
25. Suppression of human hepatoma in mice through adoptive transfer of immunity to the hepatitis B surface antigen.
Ilan Y; Gabay E; Amit G; Feder R; Galun E; Adler R; Shouval D
J Hepatol; 1997 Jul; 27(1):170-5. PubMed ID: 9252092
[TBL] [Abstract][Full Text] [Related]
26. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
Porgador A; Gilboa E
J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.
Kim KW; Kim SH; Jang JH; Lee EY; Park SW; Um JH; Lee YJ; Lee CH; Yoon S; Seo SY; Jeong MH; Lee ST; Chung BS; Kang CD
Cancer Immunol Immunother; 2004 Apr; 53(4):315-22. PubMed ID: 14685778
[TBL] [Abstract][Full Text] [Related]
29. Reversal of CD8+ T cell ignorance and induction of anti-tumor immunity by peptide-pulsed APC.
Dalyot-Herman N; Bathe OF; Malek TR
J Immunol; 2000 Dec; 165(12):6731-7. PubMed ID: 11120791
[TBL] [Abstract][Full Text] [Related]
30. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.
Fenton RG; Taub DD; Kwak LW; Smith MR; Longo DL
J Natl Cancer Inst; 1993 Aug; 85(16):1294-302. PubMed ID: 8340941
[TBL] [Abstract][Full Text] [Related]
32. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
33. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors.
Shouval D; Adler R; Ilan Y
Hepatology; 1993 Jun; 17(6):955-9. PubMed ID: 8514268
[TBL] [Abstract][Full Text] [Related]
34. Critical roles of memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow cells in sensitized recipient mice.
Nagata S; Okano S; Yonemitsu Y; Nakagawa K; Tomita Y; Yoshikai Y; Shimada M; Maehara Y; Sueishi K
Transplantation; 2006 Sep; 82(5):689-98. PubMed ID: 16969294
[TBL] [Abstract][Full Text] [Related]
35. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
[TBL] [Abstract][Full Text] [Related]
36. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
[TBL] [Abstract][Full Text] [Related]
37. Antigen is required for the activation of effector activities, whereas interleukin 2 Is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes.
Ke Y; Ma H; Kapp JA
J Exp Med; 1998 Jan; 187(1):49-57. PubMed ID: 9419210
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced augmentation of host resistance to histocompatible tumor in mice. Detection of a graft antitumor effect of syngeneic bone marrow transplantation.
Kwak LW; Grand LC; Williams RM
Transplantation; 1991 Jun; 51(6):1244-8. PubMed ID: 1904663
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
[TBL] [Abstract][Full Text] [Related]
40. The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling.
Met O; Wang M; Pedersen AE; Nissen MH; Buus S; Claesson MH
Cancer Lett; 2006 Jan; 231(2):247-56. PubMed ID: 16399226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
